MAP3K8 mutation is extremely rare in cancer27, 28, 36, 37, 38, unlike BRAF or its upstream regulator KRAS, in which somatic mutations occur with particularly high incidence in melanoma and lung cancers, respectively35, 66. This evidence concerns the gene MAP3K8 and lung cancer.